Skip to main content

Table 1 Ratings of diabetes experts of study effects and associated risk reductions of late complications in relation to format of data presentation

From: Diabetes experts' reasoning about diabetes prevention studies: a questionnaire survey

  Rating the benefit of the intervention as Estimates of corresponding reductions of late complications
  very important important not very important not important at all >75% 55–75% 35–55% 15–35% <15%
Diabetes prevention
60% diabetes risk reduction
(item 1 and 2)
35/15
(51%)
19/14
(33%)
8/1
(9%)
6/1
(7%)
7/5
(12%)
14/8
(23%)
9/5
(14%)
11/7
(19%)
25/6
(32%)
HbA1c 6.0% versus 6.1%
(item 6 and 7)
1/1
(2%)
10/7
(17%)
35/15
(51%)
22/8
(30%)
1/1
(2%)
8/2
(10%)
14/5
(19%)
8/5
(13%)
37/18
(56%)
0.288 life years gained
(item 5)
3/3
(6%)
17/9
(27%)
34/15
(50%)
13/4
(17%)
n.a. n.a. n.a. n.a. n.a.
UKPDS
HbA1c 7.0% versus 7.9%
(item 3 and 4)
22/12
(35%)
24/15
(40%)
21/4
(25%)
0/0 2/2
(4%)
7/4
(12%)
20/6
(27%)
22/13
(37%)
13/6
(20%)
41 versus 46 out of 100 patients
(item 8)
5/4
(9%)
36/17
(54%)
25/10
(36%)
1/0
(1%)
n.a. n.a. n.a. n.a. n.a.
  1. Values are numbers of the n = 69 Austrian/n = 31 German samples (percentages of all respondents). UKPDS = United Kingdom Prospective Diabetes Study [10]. Numbers may not add up to 100 due to up to 5 missing values. n.a. = not assessed